Autonomic nervous system, heart rate variability and n-3 fatty acids

Journal of Cardiovascular Medicine

Volumn 8, Issue SUPPL. 1, 2007, Pages

  Christensen, Jeppe Hagstrup ^a   Schmidt, Erik Berg ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Heart rate variability; N 3 fatty acids; Sudden cardiac death

Indexed keywords

DOCOSAHEXAENOIC ACID; OMEGA 3 FATTY ACID;

AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR RISK; CLINICAL RESEARCH; CONFERENCE PAPER; DIET SUPPLEMENTATION; ELECTROCARDIOGRAPHY MONITORING; HEART RATE VARIABILITY; HOLTER MONITORING; HUMAN; NEUROMODULATION; NON INVASIVE PROCEDURE; PREDICTION; RISK REDUCTION; SINUS RHYTHM; SUDDEN DEATH; VAGUS TONE;

ANIMALS; ARRHYTHMIAS, CARDIAC; AUTONOMIC NERVOUS SYSTEM; DIABETES MELLITUS; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; HEART RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MYOCARDIAL ISCHEMIA;

EID: 34548739691     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/01.JCM.0000289276.10675.a1     Document Type: Conference Paper

References (23)

1. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 1996; 17:354-381.
2. La Rovere MT, Bigger JT, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998; 351:478-484.
3. Youdim KA, Martin A, Joseph JA. Essential fatty acids and the brain: possible health implications. Int J Dev Neurosci 2000; 18:383-399.
4. Stein PK, Kleiger RE. Insights from the study of heart rate variability. Annu Rev Med 1999; 50:249-261.
5. Christensen JH. n-3 Fatty acids and the risk of sudden cardiac death. Emphasis on heart rate variability. Dan Med Bull 2003; 50:347-367.
6. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989; 2:757-761.
7. Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995; 274:1363-1367.
8. Albert CM, Hennekens CH, O'Donnell CJ, Ajani UA, Carey VJ, Willett WC, et al. Fish consumption and risk of sudden cardiac death. JAMA 1998; 279:23-28.
9. Siscovick DS, Raghunathan T, King I, Weinmann S, Bovbjerg VE, Kushi L, et al. Dietary intake of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. Am J Clin Nutr 2000; 71 (Suppl):208S-212S.
10. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation 1998; 98:2334-2351.
11. Villa B, Calabresi L, Chiesa G, Rise P, Galli C, Sirtori CR. Omega-3 fatty acid ethyl esters increase heart rate variability in patients with coronary disease. Pharmacol Res 2002; 45:475.
12. Maser RE, Lenhard MJ. Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment. J Clin Endocrinol Metab 2005; 90:5896-5903.
13. Hayano J, Takahashi H, Toriyama T, Mukai S, Okada A, Sakata S, et al. Prognostic value of heart rate variability during long-term follow-up in chronic haemodialysis patients with end-stage renal disease. Nephrol Dial Transplant 1999; 14:1480-1488.
14. Friedman A, Moe S. Review of the effects of omega-3 supplementation in dialysis patients. Clin J Am Soc Nephrol 2006; 1:182-192.
15. Fiedler R, Mall M, Wand C, Osten B. Short-term administration of omega-3 fatty acids in hemodialysis patients with balanced lipid metabolism. J Ren Nutr 2005; 15:253-256.
16. Tsuji H, Larson MG, Venditti FJ, Manders ES, Evans JC, Feldman CL, et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 1996; 94:2850-2855.
17. Brouwer IA, Zock PL, van Amelsvoort LG, Katan MB, Schouten EG. Association between n-3 fatty acid status in blood and electrocardiographic predictors of arrhythmia risk in healthy volunteers. Am J Cardiol 2002; 89:629-631.
18. Mozaffarian D, Geelen A, Brouwer IA, Geleijnse JM, Zock PL, Katan MB. Effect of fish oil on heart rate in humans: a metaanalysis of randomized controlled trials. Circulation 2005; 112:1945-1952.
19. Palatini P, Julius S. Elevated heart rate: a major risk factor for cardiovascular disease. Clin Exp Hypertens 2004; 26:637-644.
20. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002; 346:1113-1118.
21. Geelen A, Zock PL, Swenne CA, Brouwer IA, Schouten EG, Katan MB. Effect of n-3 fatty acids on heart rate variability and baroreflex sensitivity in middle-aged subjects. Am Heart J 2003; 146:E4.
22. Holguin F, Tellez-Rojo MM, Lazo M, Mannino D, Schwartz J, Hernandez M, et al. Cardiac autonomic changes associated with fish oil vs. soy oil supplementation in the elderly. Chest 2005; 127:1102-1107.
23. Romieu I, Tellez-Rojo MM, Lazo M, Manzano-Patino A, Cortez-Lugo M, Julien P, et al. Omega-3 fatty acid prevents heart rate variability reductions associated with particulate matter. Am J Respir Crit Care Med 2005; 172:1534-1540.